Shanghai Conant Optical Co., Ltd.

SEHK:2276 Stock Report

Market Cap: HK$7.4b

Shanghai Conant Optical Valuation

Is 2276 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2276 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 2276 (HK$17.88) is trading below our estimate of fair value (HK$56.6)

Significantly Below Fair Value: 2276 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2276?

Key metric: As 2276 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 2276. This is calculated by dividing 2276's market cap by their current earnings.
What is 2276's PE Ratio?
PE Ratio19x
EarningsCN¥377.18m
Market CapCN¥6.93b

Price to Earnings Ratio vs Peers

How does 2276's PE Ratio compare to its peers?

The above table shows the PE ratio for 2276 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average14.9x
1501 Shanghai INT Medical Instruments
26.8xn/aHK$4.8b
9997 Kangji Medical Holdings
13.9x12.1%HK$8.0b
6929 OrbusNeich Medical Group Holdings
11.1x-3.1%HK$3.4b
1763 China Isotope & Radiation
8xn/aHK$3.4b
2276 Shanghai Conant Optical
19x16.5%HK$7.4b

Price-To-Earnings vs Peers: 2276 is expensive based on its Price-To-Earnings Ratio (19x) compared to the peer average (14.9x).

Price to Earnings Ratio vs Industry

How does 2276's PE Ratio compare vs other companies in the HK Medical Equipment Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
2393 Yestar Healthcare Holdings
0.1xn/aUS$19.20m
No more companies available in this PE range
2276 19.0xIndustry Avg. 17.0xNo. of Companies5PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 2276 is expensive based on its Price-To-Earnings Ratio (19x) compared to the Hong Kong Medical Equipment industry average (17x).

Price to Earnings Ratio vs Fair Ratio

What is 2276's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2276 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19x
Fair PE Ratio13.7x

Price-To-Earnings vs Fair Ratio: 2276 is expensive based on its Price-To-Earnings Ratio (19x) compared to the estimated Fair Price-To-Earnings Ratio (13.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 2276 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$17.88
HK$16.44
-8.1%
9.5%HK$18.34HK$14.50n/a3
Dec ’25HK$14.40
HK$16.44
+14.2%
9.5%HK$18.34HK$14.50n/a3
Nov ’25HK$15.08
HK$16.44
+9.0%
9.5%HK$18.34HK$14.50n/a3
Oct ’25HK$13.90
HK$16.44
+18.3%
9.5%HK$18.34HK$14.50n/a3
Sep ’25HK$13.00
HK$16.44
+26.5%
9.5%HK$18.34HK$14.50n/a3
Aug ’25HK$11.50
HK$13.41
+16.6%
17.6%HK$15.49HK$10.10n/a3
Jul ’25HK$12.36
HK$13.44
+8.7%
17.5%HK$15.48HK$10.14n/a3
Jun ’25HK$11.10
HK$13.34
+20.2%
16.7%HK$15.07HK$10.19n/a3
May ’25HK$8.78
HK$13.34
+51.9%
16.7%HK$15.07HK$10.19n/a3
Apr ’25HK$8.51
HK$14.92
+75.4%
1.1%HK$15.08HK$14.77n/a2
Mar ’25HK$7.45
HK$14.95
+100.7%
0.9%HK$15.08HK$14.82n/a2

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 10:40
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Conant Optical Co., Ltd. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tsz-Wang TamDBS Bank Ltd
null nullGuoyuan Securities (HK) Ltd
Eason CuiKingsway Financial Services Group Limited